Rising costs, unpredictable timelines, patient recruitment, and patient adherence–just a few of the tremendous challenges clinical trials face to be successful.

Pharma companies continue to face these never-ending, insurmountable financial and reputational pressures and are BEGGING for a more efficient, cost-effective solution to this critical stage of drug development. Not surprisingly, they are actively investing in leading-edge technologies to yield this competitive edge.

We’ve invited the Head of Digital Health and MedTech from a global leader in innovation to share her powerful insights on how technology—more specifically, data analytics, device and wearable connectivity, blockchain, and AI—will intervene and transform the clinical trials of yesterday into “well-oiled machines” for superior drug development and next-gen treatments for disease.